At least 20% of people aged 65 to 74, and 50% of people over 75, have chronic kidney disease. However, the 10 largest pharmaceutical companies have only 30 nephrology trials underway compared to over 1,300 cancer trials.Why? And how do we spark innovation and gain new insights in nephrology to prevent disease and bring new therapies to those in need?
